Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ROIV
2. HUVR:IN
3. ASML
4. NVS
5. TTE
6. ANET
7. NKE
8. BE
9. PANW
10. CL

Go back to Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress
Allergan Inc (NYSE: AGN) Delayed: 193.02 --0 (-0%)
Previous Close $193.02    52 Week High $322.68 
Open $15.33    52 Week Low $186.34 
Day High $193.02    P/E 45.96 
Day Low $193.02    EPS $4.20 
Volume 43,377       

Amgen Inc (NASDAQ: AMGN) Delayed: 437.23 --0 (-0%)
Previous Close $437.23    52 Week High $176.85 
Open $437.23    52 Week Low $133.64 
Day High $437.23    P/E 65.85 
Day Low $437.23    EPS $6.64 
Volume 9,928       

DIAGEO PLC (NYSE: DEO) Delayed: 89.19 --0 (-0%)
Previous Close $89.19    52 Week High $117.95 
Open $89.19    52 Week Low $99.46 
Day High $89.19    P/E N/A 
Day Low $89.19    EPS $0.00 
Volume 11,908       

(AMEX: DGE) Delayed: 0.00 -440.99 (100%)
Previous Close $440.99    52 Week High $ 
Open $440.99    52 Week Low $ 
Day High $440.99    P/E N/A 
Day Low $440.99    EPS $ 
Volume 0